Boston Scientific price target raised to $100 from $92 at Bernstein

Bernstein analyst Lee Hambright raised the firm’s price target on Boston Scientific (BSX) to $100 from $92 and keeps an Outperform rating on the shares. Keeping up the trend from Q1 and Q2, Boston Scientific delivered another clean beat-and-raise quarter as top-line grew 18% organic and landed 4% ahead of Street estimates on strength across segments, the firm says.